Meglitinide-class tablets acting as rapid insulin secretagogues for mealtime glucose control in type 2 diabetes. Generic producers deliver to pharmacy networks, ambulatory care settings, and medical supply chains for utilization by diabetologists in combination with other antidiabetic agents.